Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Frederick Masoudi

Concepts (769)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Defibrillators, Implantable
70
2023
393
9.640
Why?
Myocardial Infarction
130
2023
1215
8.640
Why?
Heart Failure
137
2024
2329
7.840
Why?
Cardiology
64
2024
363
7.730
Why?
Registries
136
2024
2400
7.520
Why?
Percutaneous Coronary Intervention
51
2026
550
6.910
Why?
Death, Sudden, Cardiac
32
2021
242
6.050
Why?
Atrial Appendage
13
2024
36
4.510
Why?
Atrial Fibrillation
29
2024
560
4.110
Why?
Primary Prevention
24
2020
222
3.840
Why?
American Heart Association
45
2024
364
3.360
Why?
Cardiac Resynchronization Therapy
17
2023
63
3.010
Why?
United States
247
2026
16136
3.000
Why?
Cardiovascular Diseases
47
2024
2219
2.860
Why?
Hospitalization
77
2024
2475
2.810
Why?
Medicare
56
2024
920
2.800
Why?
Quality of Health Care
41
2024
702
2.720
Why?
Aged
282
2026
26432
2.590
Why?
Stroke
24
2024
1287
2.500
Why?
Ventricular Dysfunction, Left
18
2021
391
2.470
Why?
Coronary Artery Disease
23
2026
751
2.310
Why?
Practice Guidelines as Topic
35
2021
1591
2.220
Why?
Patient Readmission
31
2021
778
2.180
Why?
Hospitals
33
2024
738
2.150
Why?
Hospital Mortality
51
2024
1051
2.140
Why?
Aged, 80 and over
126
2024
8391
2.110
Why?
Secondary Prevention
14
2021
248
2.080
Why?
Humans
493
2026
146342
2.040
Why?
Quality Indicators, Health Care
27
2021
343
1.960
Why?
Risk Assessment
63
2024
3712
1.850
Why?
Quality Assurance, Health Care
27
2015
349
1.850
Why?
Angiotensin-Converting Enzyme Inhibitors
31
2023
228
1.800
Why?
Societies, Medical
21
2024
907
1.790
Why?
Exercise Test
18
2021
637
1.790
Why?
Male
311
2026
73396
1.760
Why?
Treatment Outcome
112
2025
11821
1.730
Why?
Adrenergic beta-Antagonists
28
2018
253
1.710
Why?
Electric Countershock
11
2019
126
1.700
Why?
Female
311
2026
79499
1.670
Why?
Risk Factors
107
2024
10921
1.640
Why?
Stroke Volume
34
2024
652
1.560
Why?
Sex Factors
34
2020
2107
1.560
Why?
Acute Coronary Syndrome
8
2024
299
1.480
Why?
Middle Aged
178
2026
36619
1.440
Why?
Arrhythmias, Cardiac
10
2020
358
1.410
Why?
Anti-Arrhythmia Agents
7
2018
144
1.390
Why?
Cardiac Catheterization
13
2024
571
1.350
Why?
Patient Discharge
28
2023
997
1.340
Why?
Forecasting
6
2022
388
1.330
Why?
Electrocardiography
19
2020
667
1.330
Why?
China
43
2022
280
1.330
Why?
Retrospective Studies
119
2023
17438
1.310
Why?
Coronary Artery Bypass
12
2026
269
1.280
Why?
Acute Kidney Injury
13
2024
866
1.250
Why?
Quality Improvement
19
2024
1354
1.230
Why?
Health Status
20
2020
827
1.210
Why?
Coronary Disease
13
2019
380
1.210
Why?
Myocardial Ischemia
10
2019
286
1.210
Why?
Time Factors
68
2024
7109
1.160
Why?
Practice Patterns, Physicians'
21
2019
1408
1.130
Why?
Mineralocorticoid Receptor Antagonists
11
2022
69
1.120
Why?
Healthcare Disparities
15
2024
733
1.100
Why?
Advisory Committees
14
2021
228
1.100
Why?
Patient Selection
21
2026
728
1.090
Why?
Fee-for-Service Plans
8
2021
98
1.090
Why?
Ventricular Function, Left
17
2022
541
1.060
Why?
Follow-Up Studies
57
2021
5439
1.040
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
14
2020
449
1.020
Why?
Home Care Services
7
2019
293
1.000
Why?
Anemia
9
2017
190
0.990
Why?
Guideline Adherence
19
2020
594
0.990
Why?
Decision Support Techniques
8
2021
478
0.960
Why?
Hypertension
17
2022
1272
0.960
Why?
Angina Pectoris
9
2018
76
0.960
Why?
Survival Rate
38
2021
2092
0.950
Why?
Thiazolidinediones
5
2010
142
0.930
Why?
Age Factors
37
2021
3347
0.930
Why?
Myocardial Reperfusion
8
2016
58
0.920
Why?
Cohort Studies
53
2024
6077
0.920
Why?
Aspirin
14
2022
405
0.910
Why?
Hospital Costs
3
2019
131
0.900
Why?
Length of Stay
14
2020
1358
0.900
Why?
Patient Care
2
2020
120
0.890
Why?
Bradycardia
3
2021
63
0.890
Why?
Angioplasty, Balloon, Coronary
12
2012
156
0.880
Why?
Diabetes Mellitus
17
2022
1101
0.880
Why?
Diagnostic Techniques, Cardiovascular
5
2019
16
0.870
Why?
Cardiac Resynchronization Therapy Devices
6
2020
18
0.860
Why?
Clinical Decision-Making
9
2021
365
0.860
Why?
Evidence-Based Medicine
13
2019
731
0.860
Why?
Ambulatory Care
7
2020
628
0.850
Why?
Postoperative Hemorrhage
5
2021
106
0.850
Why?
Coronary Angiography
12
2024
325
0.840
Why?
Randomized Controlled Trials as Topic
11
2025
1763
0.840
Why?
Quality of Life
21
2020
3200
0.790
Why?
Pacemaker, Artificial
4
2021
127
0.780
Why?
Survival Analysis
22
2021
1378
0.770
Why?
Antihypertensive Agents
9
2022
519
0.770
Why?
Multimorbidity
2
2021
65
0.770
Why?
Insurance, Health
4
2021
318
0.750
Why?
ST Elevation Myocardial Infarction
7
2021
65
0.740
Why?
Disease Management
10
2021
651
0.740
Why?
Hypoglycemic Agents
15
2025
1412
0.730
Why?
Tachycardia, Ventricular
3
2019
179
0.720
Why?
Multivariate Analysis
32
2018
1543
0.700
Why?
Heart Diseases
7
2020
343
0.700
Why?
Myocardial Revascularization
11
2018
85
0.690
Why?
Data Accuracy
1
2022
64
0.690
Why?
Incidence
27
2021
2936
0.690
Why?
Research Report
7
2021
89
0.680
Why?
Odds Ratio
22
2018
1077
0.680
Why?
Cross-Sectional Studies
38
2023
5899
0.680
Why?
Text Messaging
5
2025
188
0.680
Why?
Non-ST Elevated Myocardial Infarction
4
2024
27
0.680
Why?
Creatinine
13
2024
511
0.680
Why?
Social Responsibility
3
2016
52
0.670
Why?
Clinical Trials as Topic
10
2022
1064
0.660
Why?
Radial Artery
1
2021
74
0.650
Why?
Insurance Carriers
1
2021
14
0.650
Why?
Prognosis
33
2024
4351
0.630
Why?
Health Care Costs
5
2019
423
0.620
Why?
Cardiac Output, Low
6
2006
53
0.610
Why?
Logistic Models
25
2018
2126
0.600
Why?
Hemorrhage
11
2024
825
0.600
Why?
Minority Groups
3
2026
286
0.590
Why?
Guidelines as Topic
2
2021
267
0.580
Why?
Prospective Studies
42
2024
8123
0.580
Why?
Hyperglycemia
9
2025
384
0.570
Why?
Cardiovascular Agents
5
2021
165
0.570
Why?
Prostheses and Implants
2
2020
137
0.560
Why?
Spironolactone
4
2022
40
0.550
Why?
Delivery of Health Care
6
2020
947
0.550
Why?
Patient Admission
11
2019
216
0.540
Why?
Renal Insufficiency, Chronic
6
2018
640
0.540
Why?
Transcatheter Aortic Valve Replacement
4
2021
153
0.530
Why?
Comorbidity
26
2019
1665
0.530
Why?
Pregnancy Complications, Infectious
1
2022
438
0.520
Why?
Cardiologists
1
2017
45
0.520
Why?
Databases, Factual
13
2020
1493
0.510
Why?
Health Policy
9
2017
399
0.510
Why?
Drug Prescriptions
9
2018
314
0.510
Why?
Hemoglobins
7
2017
384
0.500
Why?
Predictive Value of Tests
22
2018
2113
0.490
Why?
Research Design
12
2022
1143
0.490
Why?
Glomerular Filtration Rate
8
2023
745
0.480
Why?
Cardiac Surgical Procedures
6
2018
611
0.480
Why?
Echocardiography, Stress
5
2018
29
0.470
Why?
Intra-Aortic Balloon Pumping
3
2021
19
0.470
Why?
Chest Pain
5
2020
100
0.460
Why?
Platelet Aggregation Inhibitors
10
2021
499
0.460
Why?
Angina, Unstable
4
2016
83
0.460
Why?
Patient Transfer
5
2019
224
0.460
Why?
Diabetes Mellitus, Type 2
10
2025
2623
0.460
Why?
Health Resources
1
2017
131
0.460
Why?
Angiotensin Receptor Antagonists
8
2023
115
0.450
Why?
Diabetic Angiopathies
5
2018
265
0.450
Why?
Blood Pressure
11
2022
1765
0.440
Why?
Endovascular Procedures
1
2020
390
0.430
Why?
Benchmarking
5
2021
193
0.430
Why?
Health Status Disparities
6
2024
322
0.430
Why?
Proportional Hazards Models
19
2019
1331
0.430
Why?
Septal Occluder Device
1
2015
37
0.430
Why?
Metformin
5
2007
328
0.420
Why?
Machine Learning
5
2021
594
0.420
Why?
Cardiomyopathies
2
2015
340
0.420
Why?
Health Services Research
2
2007
390
0.420
Why?
Blood Glucose
11
2025
2360
0.410
Why?
Patient-Centered Care
7
2019
553
0.410
Why?
Mortality
7
2019
375
0.400
Why?
Torsades de Pointes
1
2013
23
0.390
Why?
Postoperative Complications
6
2019
3034
0.390
Why?
Medication Adherence
8
2019
535
0.390
Why?
Heart Function Tests
4
2019
59
0.380
Why?
Equipment Design
4
2017
520
0.380
Why?
Syncope
1
2013
48
0.380
Why?
Narcotics
1
2013
57
0.380
Why?
Shock, Cardiogenic
5
2021
65
0.380
Why?
Hemostasis, Surgical
1
2013
25
0.380
Why?
Heart Valve Prosthesis Implantation
3
2021
197
0.380
Why?
Health Expenditures
4
2019
198
0.360
Why?
Prosthesis Implantation
4
2019
156
0.360
Why?
Blood Loss, Surgical
1
2013
117
0.360
Why?
Prevalence
15
2022
2861
0.350
Why?
Cardiovascular System
2
2024
137
0.350
Why?
Product Surveillance, Postmarketing
4
2020
74
0.350
Why?
Continuity of Patient Care
3
2013
298
0.350
Why?
Embolism
2
2022
49
0.350
Why?
Warfarin
6
2022
179
0.350
Why?
Risk
10
2015
920
0.350
Why?
Comparative Effectiveness Research
6
2019
171
0.340
Why?
Methadone
1
2013
130
0.340
Why?
Drug-Eluting Stents
3
2020
88
0.340
Why?
Acculturation
1
2012
55
0.340
Why?
Adult
51
2025
41087
0.340
Why?
Hospital Records
1
2011
10
0.340
Why?
Convalescence
1
2011
19
0.340
Why?
Surveys and Questionnaires
16
2021
6073
0.340
Why?
Longitudinal Studies
12
2020
3017
0.330
Why?
Patient Education as Topic
5
2019
770
0.330
Why?
Employee Performance Appraisal
1
2010
6
0.330
Why?
Epidemiologic Studies
2
2017
70
0.330
Why?
Professionalism
2
2021
27
0.330
Why?
Mitral Valve
2
2021
96
0.330
Why?
Chi-Square Distribution
11
2017
517
0.330
Why?
Morbidity
6
2022
319
0.330
Why?
Drug Costs
2
2017
116
0.320
Why?
Delivery of Health Care, Integrated
3
2021
305
0.320
Why?
Nursing
1
2010
37
0.320
Why?
Pragmatic Clinical Trials as Topic
3
2025
135
0.320
Why?
Mitral Valve Insufficiency
2
2021
69
0.310
Why?
Heart-Assist Devices
3
2021
572
0.310
Why?
Severity of Illness Index
14
2020
2921
0.310
Why?
Kidney Diseases
3
2009
428
0.310
Why?
Social Determinants of Health
2
2024
317
0.310
Why?
Colorado
11
2021
4595
0.310
Why?
Hospitals, Urban
7
2017
140
0.300
Why?
Outpatients
7
2018
440
0.300
Why?
Peripheral Arterial Disease
3
2010
507
0.300
Why?
Anticoagulants
9
2022
746
0.300
Why?
Healthy Lifestyle
2
2020
38
0.300
Why?
Thrombolytic Therapy
4
2016
165
0.290
Why?
Drug Utilization
6
2015
171
0.290
Why?
Pneumonia
5
2017
635
0.290
Why?
Contrast Media
6
2024
493
0.290
Why?
Medicine, Chinese Traditional
2
2019
8
0.290
Why?
Thromboembolism
2
2022
129
0.290
Why?
Cost Savings
2
2019
87
0.280
Why?
Drugs, Chinese Herbal
2
2019
24
0.280
Why?
Health Literacy
1
2011
183
0.280
Why?
Health Status Indicators
4
2020
167
0.280
Why?
Water-Electrolyte Balance
2
2007
37
0.280
Why?
Device Approval
2
2020
19
0.270
Why?
Ischemic Attack, Transient
2
2022
71
0.270
Why?
Heart Rate
5
2021
846
0.270
Why?
Radiology
1
2010
175
0.270
Why?
Exercise Tolerance
2
2008
289
0.270
Why?
Sex Distribution
5
2017
382
0.270
Why?
Clinical Competence
4
2017
1272
0.270
Why?
Physicians
5
2024
955
0.270
Why?
Cause of Death
6
2020
456
0.270
Why?
Diagnostic Imaging
5
2013
340
0.270
Why?
Myocardial Perfusion Imaging
2
2018
50
0.270
Why?
Ezetimibe
2
2018
24
0.260
Why?
Fluorobenzenes
1
2007
17
0.260
Why?
Bundle-Branch Block
4
2017
37
0.260
Why?
Nurses, Community Health
2
2019
38
0.260
Why?
Hospitals, Veterans
3
2016
256
0.260
Why?
Survivors
3
2012
526
0.250
Why?
Hyperkalemia
4
2016
35
0.250
Why?
Emergency Service, Hospital
6
2020
2363
0.250
Why?
Hospitals, Low-Volume
2
2024
26
0.250
Why?
Systole
5
2013
179
0.250
Why?
Kaplan-Meier Estimate
6
2016
970
0.250
Why?
Health Knowledge, Attitudes, Practice
4
2021
1408
0.250
Why?
Epidemiologic Research Design
1
2006
27
0.240
Why?
Hospitals, High-Volume
2
2024
51
0.240
Why?
Coronary Vessels
2
2019
245
0.240
Why?
Inpatients
8
2014
540
0.240
Why?
Attitude of Health Personnel
3
2012
1219
0.240
Why?
Propensity Score
7
2020
376
0.230
Why?
Consensus
5
2024
467
0.230
Why?
Thoracic Surgery
4
2021
145
0.220
Why?
Cholesterol, LDL
5
2018
363
0.220
Why?
Contraindications
8
2015
88
0.220
Why?
Health Care Reform
2
2018
110
0.220
Why?
Echocardiography
5
2019
645
0.220
Why?
Troponin
3
2017
50
0.220
Why?
Diagnostic Errors
1
2006
178
0.220
Why?
Prosthesis Design
3
2016
358
0.220
Why?
Antithrombins
2
2017
71
0.220
Why?
Bibliometrics
2
2016
68
0.210
Why?
Monitoring, Physiologic
3
2017
279
0.210
Why?
Exercise
5
2019
2213
0.210
Why?
Data Collection
5
2017
650
0.210
Why?
Efficiency, Organizational
3
2018
144
0.210
Why?
Polypharmacy
2
2015
94
0.210
Why?
Hospitals, Rural
4
2017
49
0.210
Why?
Acute Disease
11
2019
1038
0.210
Why?
Angiotensin II Type 1 Receptor Blockers
2
2015
39
0.200
Why?
Purinergic P2Y Receptor Antagonists
1
2024
71
0.200
Why?
Income
3
2020
206
0.200
Why?
Heart Conduction System
3
2015
96
0.200
Why?
Electrocardiography, Ambulatory
2
2015
64
0.200
Why?
Noncommunicable Diseases
1
2024
21
0.200
Why?
Pyrimidines
1
2007
532
0.200
Why?
Patient Care Planning
1
2025
170
0.200
Why?
Confidence Intervals
4
2014
329
0.200
Why?
Telemedicine
4
2025
966
0.200
Why?
Sulfonamides
1
2007
594
0.200
Why?
Coronary Care Units
3
2015
27
0.190
Why?
Time-to-Treatment
4
2019
257
0.190
Why?
Professional Practice Gaps
2
2020
15
0.190
Why?
Stents
5
2016
554
0.190
Why?
Cross Infection
2
2024
258
0.190
Why?
Administrative Claims, Healthcare
2
2020
29
0.190
Why?
Treatment Refusal
3
2008
99
0.190
Why?
Periodicals as Topic
2
2016
214
0.180
Why?
Thiazoles
1
2003
139
0.180
Why?
Referral and Consultation
5
2017
881
0.180
Why?
Canada
6
2026
432
0.180
Why?
Skilled Nursing Facilities
2
2017
152
0.180
Why?
Computed Tomography Angiography
2
2020
151
0.180
Why?
Pericardial Effusion
1
2022
22
0.180
Why?
Biomarkers
15
2025
4340
0.180
Why?
Renal Insufficiency
1
2004
173
0.170
Why?
Biomedical Research
1
2008
729
0.170
Why?
Technology Transfer
1
2021
9
0.170
Why?
Culturally Competent Care
2
2019
66
0.170
Why?
Primary Health Care
3
2025
1776
0.170
Why?
Mass Screening
4
2019
1307
0.170
Why?
Catheter Ablation
2
2017
355
0.170
Why?
Accreditation
2
2020
100
0.170
Why?
Hypercholesterolemia
1
2022
95
0.170
Why?
Sex Characteristics
2
2022
801
0.170
Why?
Administrative Personnel
2
2019
33
0.170
Why?
Tomography, Emission-Computed, Single-Photon
2
2019
104
0.170
Why?
Models, Statistical
5
2019
669
0.170
Why?
Risk Reduction Behavior
2
2020
220
0.170
Why?
Patient Participation
2
2016
457
0.160
Why?
Manufacturing Industry
1
2020
6
0.160
Why?
Physician-Patient Relations
3
2014
597
0.160
Why?
Long Term Adverse Effects
1
2020
13
0.160
Why?
Fibrinolytic Agents
4
2022
303
0.160
Why?
Creatine Kinase, MB Form
2
2017
6
0.160
Why?
Decision Making
7
2016
993
0.160
Why?
Geographic Mapping
1
2020
26
0.160
Why?
Ethics, Medical
1
2021
90
0.160
Why?
Prosthesis Failure
2
2018
126
0.160
Why?
Recovery of Function
6
2020
725
0.160
Why?
Social Class
3
2019
260
0.150
Why?
Managed Care Programs
2
2011
137
0.150
Why?
Benzoxazoles
1
2020
20
0.150
Why?
Femoral Artery
1
2021
183
0.150
Why?
Bacteremia
2
2021
218
0.150
Why?
Young Adult
12
2022
14330
0.150
Why?
Cardiac Pacing, Artificial
2
2010
83
0.150
Why?
Amyloidosis
1
2020
43
0.150
Why?
New York
2
2017
128
0.150
Why?
Neprilysin
1
2020
47
0.150
Why?
Body Mass Index
5
2021
2458
0.150
Why?
Reoperation
2
2020
645
0.150
Why?
Dose-Response Relationship, Drug
6
2014
2022
0.150
Why?
International Cooperation
2
2018
193
0.150
Why?
Extracorporeal Membrane Oxygenation
2
2021
370
0.150
Why?
Models, Economic
1
2019
63
0.150
Why?
Self Care
2
2019
396
0.150
Why?
Health Care Surveys
5
2019
541
0.150
Why?
Digoxin
1
2019
27
0.150
Why?
Reproducibility of Results
9
2021
3416
0.140
Why?
Reimbursement Mechanisms
1
2019
79
0.140
Why?
Information Storage and Retrieval
1
2020
121
0.140
Why?
Cardiology Service, Hospital
1
2019
29
0.140
Why?
Multiple Chronic Conditions
1
2019
34
0.140
Why?
Thinness
1
2019
100
0.140
Why?
United States Food and Drug Administration
2
2020
208
0.140
Why?
Costs and Cost Analysis
1
2019
217
0.140
Why?
Return to Work
1
2018
21
0.140
Why?
Vena Cava Filters
2
2018
68
0.140
Why?
Anticholesteremic Agents
2
2017
156
0.140
Why?
Disease Progression
6
2013
2867
0.140
Why?
Medical Records
5
2016
193
0.140
Why?
Nursing Staff
1
2019
41
0.140
Why?
Frailty
1
2022
208
0.140
Why?
Nutrition Surveys
4
2023
270
0.140
Why?
Fraud
1
2018
10
0.140
Why?
Equipment Safety
2
2015
38
0.140
Why?
Regression Analysis
6
2017
999
0.140
Why?
Drug Utilization Review
2
2012
60
0.140
Why?
Medical Record Linkage
2
2015
68
0.140
Why?
Medical Overuse
1
2018
31
0.140
Why?
Transitional Care
1
2018
46
0.130
Why?
Ticlopidine
2
2015
52
0.130
Why?
Serine Proteinase Inhibitors
1
2018
48
0.130
Why?
Liability, Legal
1
2018
43
0.130
Why?
Coronary Stenosis
1
2018
40
0.130
Why?
Data Mining
1
2018
113
0.130
Why?
Dabigatran
1
2017
30
0.130
Why?
Subacute Care
1
2018
85
0.130
Why?
Hypertrophy, Left Ventricular
2
2008
124
0.130
Why?
Socioeconomic Factors
7
2019
1327
0.130
Why?
Patient Care Management
1
2017
54
0.130
Why?
Health Services Accessibility
4
2019
1107
0.130
Why?
Arteriosclerosis
1
2017
82
0.130
Why?
Heart Arrest
3
2021
411
0.130
Why?
Depression
6
2012
1575
0.130
Why?
Health Surveys
3
2015
511
0.130
Why?
Vaccines
1
2022
389
0.130
Why?
Ambulatory Care Facilities
1
2019
269
0.130
Why?
Telemetry
1
2017
41
0.130
Why?
Simvastatin
1
2017
58
0.130
Why?
Patient Preference
2
2026
226
0.120
Why?
Postoperative Care
4
2013
301
0.120
Why?
Pulmonary Embolism
2
2018
246
0.120
Why?
Elective Surgical Procedures
1
2018
216
0.120
Why?
Recurrence
3
2018
1133
0.120
Why?
Educational Status
1
2019
466
0.120
Why?
Insurance Coverage
1
2018
248
0.120
Why?
Policy
2
2022
147
0.120
Why?
Dyslipidemias
1
2018
184
0.120
Why?
Anterior Wall Myocardial Infarction
1
2015
4
0.110
Why?
Veterans Health
1
2017
188
0.110
Why?
Blood Coagulation
1
2017
267
0.110
Why?
Documentation
1
2017
202
0.110
Why?
Factor Xa Inhibitors
1
2017
195
0.110
Why?
Pyridones
1
2017
210
0.110
Why?
Equipment and Supplies
1
2015
36
0.110
Why?
Kidney
3
2023
1498
0.110
Why?
Patient Reported Outcome Measures
2
2019
516
0.110
Why?
Clinical Chemistry Tests
1
2015
6
0.110
Why?
Obesity
3
2019
3131
0.110
Why?
Sepsis
1
2021
669
0.110
Why?
Drug Substitution
1
2015
62
0.110
Why?
Blood Vessels
1
2016
164
0.110
Why?
Rivaroxaban
1
2017
270
0.110
Why?
Mandatory Reporting
1
2015
45
0.110
Why?
Drug Monitoring
2
2021
399
0.110
Why?
Hyperlipidemias
1
2015
120
0.110
Why?
Weight Reduction Programs
1
2016
140
0.110
Why?
Japan
3
2021
149
0.110
Why?
Linear Models
4
2017
857
0.110
Why?
Qualitative Research
3
2019
1734
0.110
Why?
United States Department of Veterans Affairs
2
2017
777
0.100
Why?
Ambulatory Surgical Procedures
1
2015
82
0.100
Why?
Aortic Valve Stenosis
1
2017
255
0.100
Why?
Aortic Valve
1
2017
360
0.100
Why?
Cardiac Imaging Techniques
1
2014
24
0.100
Why?
Patient Compliance
3
2008
589
0.100
Why?
Preventive Health Services
1
2015
154
0.100
Why?
Adolescent
9
2021
22557
0.100
Why?
Single-Blind Method
3
2019
313
0.100
Why?
Urination Disorders
1
2013
15
0.100
Why?
Endarterectomy, Carotid
1
2014
63
0.100
Why?
Community Health Services
2
2013
229
0.100
Why?
Residence Characteristics
5
2015
385
0.100
Why?
Workplace
1
2015
268
0.100
Why?
Pulmonary Valve
1
2015
100
0.100
Why?
Administration, Oral
5
2017
872
0.100
Why?
Pyrazoles
1
2017
517
0.100
Why?
Venous Thromboembolism
1
2018
332
0.100
Why?
Cerebral Hemorrhage
1
2014
125
0.100
Why?
Ventricular Premature Complexes
1
2013
37
0.100
Why?
Patient Safety
2
2018
352
0.090
Why?
Lung Transplantation
1
2016
326
0.090
Why?
Myocardium
2
2015
948
0.090
Why?
Body Weight
1
2017
968
0.090
Why?
Hirudins
1
2013
52
0.090
Why?
Gait
1
2016
322
0.090
Why?
Cardiac Rehabilitation
2
2017
48
0.090
Why?
Observation
1
2012
51
0.090
Why?
ROC Curve
3
2019
617
0.090
Why?
Pacific States
1
2012
7
0.090
Why?
New England
1
2012
37
0.090
Why?
Communication
1
2019
980
0.090
Why?
Poisson Distribution
2
2012
77
0.090
Why?
Drug Therapy, Combination
4
2019
1036
0.090
Why?
Health Maintenance Organizations
1
2012
106
0.090
Why?
Erythrocyte Indices
1
2012
33
0.090
Why?
Cost-Benefit Analysis
5
2017
640
0.090
Why?
Program Evaluation
1
2016
952
0.090
Why?
Patient Satisfaction
2
2025
706
0.090
Why?
Reimbursement, Incentive
2
2015
44
0.090
Why?
Activities of Daily Living
3
2012
442
0.090
Why?
Patient Acceptance of Health Care
1
2019
881
0.090
Why?
Meta-Analysis as Topic
1
2012
173
0.090
Why?
Drug Resistance
1
2012
145
0.090
Why?
Pregnancy
2
2022
7230
0.090
Why?
National Health Programs
2
2015
23
0.090
Why?
Phlebotomy
1
2011
21
0.080
Why?
Evaluation Studies as Topic
1
2011
161
0.080
Why?
Social Environment
1
2013
246
0.080
Why?
Hospitals, Teaching
3
2021
121
0.080
Why?
Rural Population
4
2019
677
0.080
Why?
Angioplasty
1
2011
49
0.080
Why?
History, 21st Century
1
2012
224
0.080
Why?
Clinical Medicine
1
2011
26
0.080
Why?
Laboratories, Hospital
1
2011
14
0.080
Why?
Independent Living
1
2012
114
0.080
Why?
Carotid Artery Diseases
1
2011
70
0.080
Why?
Pilot Projects
3
2026
1888
0.080
Why?
History, 20th Century
1
2012
330
0.080
Why?
Cluster Analysis
1
2012
496
0.080
Why?
Physical Fitness
1
2012
209
0.080
Why?
Opiate Substitution Treatment
1
2013
195
0.080
Why?
Aftercare
2
2022
225
0.080
Why?
Eligibility Determination
3
2017
73
0.080
Why?
Education, Medical, Graduate
1
2015
568
0.080
Why?
Sickness Impact Profile
2
2012
67
0.080
Why?
Diuretics
2
2012
66
0.080
Why?
Antibodies, Monoclonal
1
2017
1512
0.080
Why?
Potassium
2
2013
151
0.080
Why?
Depressive Disorder
2
2010
361
0.080
Why?
Heart Transplantation
1
2016
682
0.080
Why?
Caregivers
1
2019
1080
0.080
Why?
Recombinant Proteins
1
2013
1361
0.070
Why?
Asia
2
2020
69
0.070
Why?
Cardiopulmonary Resuscitation
1
2013
334
0.070
Why?
Peptide Fragments
1
2013
693
0.070
Why?
Poverty
1
2013
530
0.070
Why?
Cost of Illness
3
2015
323
0.070
Why?
Probability
1
2010
309
0.070
Why?
Attitude to Health
1
2012
421
0.070
Why?
Overweight
2
2019
614
0.070
Why?
Public Health Informatics
1
2008
10
0.070
Why?
Prosthesis-Related Infections
1
2010
100
0.070
Why?
Cardiotonic Agents
2
2013
96
0.070
Why?
Observational Studies as Topic
2
2020
133
0.070
Why?
Electrophysiologic Techniques, Cardiac
1
2008
82
0.070
Why?
Emergency Medical Services
1
2015
680
0.070
Why?
Urban Population
3
2017
497
0.070
Why?
Vascular Diseases
1
2010
252
0.070
Why?
Rosuvastatin Calcium
1
2007
21
0.070
Why?
California
2
2006
475
0.070
Why?
Internal Medicine
1
2010
280
0.070
Why?
Atrial Flutter
1
2008
47
0.060
Why?
Proprotein Convertase 9
2
2018
88
0.060
Why?
Rehabilitation
1
2007
20
0.060
Why?
Palliative Care
2
2007
1032
0.060
Why?
Certificate of Need
1
2007
2
0.060
Why?
Reimbursement, Disproportionate Share
1
2007
1
0.060
Why?
Diabetes Mellitus, Type 1
2
2017
3930
0.060
Why?
Retreatment
2
2020
79
0.060
Why?
Protective Factors
2
2018
97
0.060
Why?
Insulin
3
2013
2525
0.060
Why?
Treatment Failure
1
2007
361
0.060
Why?
Reperfusion
1
2006
53
0.060
Why?
Renal Dialysis
3
2016
461
0.060
Why?
Cerebrovascular Disorders
2
2017
103
0.060
Why?
Image Interpretation, Computer-Assisted
1
2009
295
0.060
Why?
Blood Urea Nitrogen
1
2006
53
0.060
Why?
Terminology as Topic
2
2024
253
0.060
Why?
Edema
1
2007
131
0.060
Why?
Fatty Acids, Nonesterified
1
2006
154
0.060
Why?
Interviews as Topic
3
2021
930
0.060
Why?
Vulnerable Populations
1
2007
178
0.060
Why?
Gastrointestinal Diseases
1
2007
220
0.060
Why?
International Classification of Diseases
2
2021
142
0.050
Why?
Body Temperature
1
2006
228
0.050
Why?
Endocarditis
2
2010
40
0.050
Why?
Natriuretic Peptide, Brain
1
2005
110
0.050
Why?
Heart Valves
1
2005
44
0.050
Why?
Opioid-Related Disorders
1
2013
634
0.050
Why?
Atrial Function, Left
1
2024
9
0.050
Why?
Specialization
1
2005
137
0.050
Why?
Appointments and Schedules
1
2025
97
0.050
Why?
Hospital-Physician Relations
1
2024
3
0.050
Why?
Hypoglycemia
1
2009
490
0.050
Why?
Motivation
2
2019
605
0.050
Why?
Cultural Characteristics
1
2004
65
0.050
Why?
Databases as Topic
3
2010
70
0.050
Why?
Medicine
1
2005
127
0.050
Why?
Weight Gain
1
2007
562
0.050
Why?
Multicenter Studies as Topic
1
2025
417
0.050
Why?
Medication Therapy Management
2
2017
73
0.050
Why?
Research
2
2008
421
0.050
Why?
Ibuprofen
1
2003
87
0.050
Why?
Drug Administration Schedule
2
2015
790
0.050
Why?
Michigan
2
2015
203
0.050
Why?
Tomography, X-Ray Computed
2
2012
2786
0.050
Why?
Health Services Needs and Demand
2
2016
287
0.040
Why?
Diabetes Complications
1
2003
219
0.040
Why?
Feasibility Studies
1
2026
1135
0.040
Why?
Health Promotion
1
2008
786
0.040
Why?
Weight Loss
1
2007
858
0.040
Why?
Analysis of Variance
1
2004
1298
0.040
Why?
Diagnosis-Related Groups
1
2021
34
0.040
Why?
Maryland
1
2021
67
0.040
Why?
Gastrointestinal Hemorrhage
1
2022
134
0.040
Why?
Smoking Cessation
2
2020
442
0.040
Why?
Assisted Circulation
1
2021
26
0.040
Why?
Reminder Systems
1
2022
149
0.040
Why?
Medical Device Legislation
1
2020
3
0.040
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2003
344
0.040
Why?
Standard of Care
1
2021
81
0.040
Why?
Decision Trees
2
2016
76
0.040
Why?
Likelihood Functions
1
2020
138
0.040
Why?
Matched-Pair Analysis
1
2020
38
0.040
Why?
Coronary Thrombosis
1
2020
25
0.040
Why?
Latin America
1
2020
96
0.040
Why?
Coronary Restenosis
1
2020
22
0.040
Why?
Argentina
1
2019
28
0.040
Why?
Medicaid
2
2017
477
0.040
Why?
Family Practice
1
2004
422
0.040
Why?
Case-Control Studies
3
2022
3647
0.040
Why?
Mental Disorders
1
2008
1148
0.040
Why?
Brazil
1
2019
179
0.040
Why?
Evidence-Based Practice
2
2013
231
0.040
Why?
Pulmonary Disease, Chronic Obstructive
3
2015
928
0.040
Why?
Combined Modality Therapy
2
2014
1271
0.040
Why?
Health Personnel
2
2018
754
0.040
Why?
Risk Adjustment
1
2019
86
0.040
Why?
Health Communication
1
2019
52
0.040
Why?
United States Government Agencies
1
2018
5
0.030
Why?
Hypertension, Pulmonary
1
2010
1957
0.030
Why?
Cardiopulmonary Bypass
1
2020
217
0.030
Why?
Retirement
1
2018
35
0.030
Why?
Clinical Audit
1
2018
14
0.030
Why?
Hospital Charges
1
2018
45
0.030
Why?
Insulin Resistance
1
2006
1247
0.030
Why?
Sample Size
1
2018
124
0.030
Why?
Malpractice
1
2018
45
0.030
Why?
Internationality
1
2018
156
0.030
Why?
F Factor
1
2017
4
0.030
Why?
Positron-Emission Tomography
1
2019
343
0.030
Why?
Puerperal Disorders
1
2018
35
0.030
Why?
Health Facility Size
1
2017
13
0.030
Why?
Pregnancy Complications, Cardiovascular
1
2018
83
0.030
Why?
Administration, Intravenous
1
2018
172
0.030
Why?
Public Health Surveillance
1
2017
84
0.030
Why?
Atherosclerosis
1
2021
410
0.030
Why?
Drug Approval
1
2017
94
0.030
Why?
Insurance, Health, Reimbursement
1
2017
97
0.030
Why?
Arabidopsis Proteins
1
2017
78
0.030
Why?
Renin-Angiotensin System
1
2017
80
0.030
Why?
Data Interpretation, Statistical
1
2018
368
0.030
Why?
Preoperative Care
2
2010
396
0.030
Why?
Statistics as Topic
2
2008
279
0.030
Why?
Algorithms
2
2015
1849
0.030
Why?
Down-Regulation
1
2018
614
0.030
Why?
Spain
1
2015
50
0.030
Why?
Australia
1
2016
291
0.030
Why?
Health Care Sector
1
2015
25
0.030
Why?
Cooperative Behavior
2
2009
471
0.030
Why?
Interinstitutional Relations
1
2015
56
0.030
Why?
Pentetic Acid
1
1995
13
0.030
Why?
Urinary Reservoirs, Continent
1
1995
5
0.030
Why?
Hospital Bed Capacity
1
2015
28
0.030
Why?
Industry
1
2015
43
0.030
Why?
Classification
1
2015
44
0.030
Why?
Health Care Rationing
1
2015
54
0.030
Why?
Urban Health Services
1
2015
68
0.030
Why?
Journal Impact Factor
1
2015
29
0.030
Why?
Conflict of Interest
1
2015
55
0.030
Why?
Life Style
1
2017
496
0.030
Why?
Operative Time
1
2015
195
0.030
Why?
Plaque, Atherosclerotic
1
2015
60
0.030
Why?
Peer Review, Research
1
2015
36
0.030
Why?
Frail Elderly
1
2015
141
0.030
Why?
Access to Information
1
2015
46
0.030
Why?
Medically Uninsured
1
2015
134
0.030
Why?
Health Behavior
2
2015
802
0.030
Why?
Magnetic Resonance Imaging
2
2019
3926
0.030
Why?
Carcinoma, Transitional Cell
1
1995
70
0.030
Why?
Early Diagnosis
1
2015
251
0.030
Why?
Age Distribution
2
2005
399
0.030
Why?
Markov Chains
2
2009
129
0.030
Why?
Double-Blind Method
1
2019
2070
0.030
Why?
Ischemia
1
2018
421
0.030
Why?
Academic Medical Centers
2
2009
561
0.030
Why?
Physical Examination
1
2015
237
0.030
Why?
Chronic Disease
3
2005
1827
0.030
Why?
Clinical Protocols
1
2016
282
0.030
Why?
Drug Hypersensitivity
1
2015
93
0.030
Why?
Organometallic Compounds
1
1995
110
0.030
Why?
Ownership
1
2015
116
0.030
Why?
Jejunum
1
1994
36
0.030
Why?
Rural Health Services
1
2015
139
0.020
Why?
Epidemiologic Methods
1
2014
91
0.020
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2013
17
0.020
Why?
Liver Cirrhosis
1
2015
278
0.020
Why?
Age of Onset
1
2015
558
0.020
Why?
Observer Variation
1
2014
356
0.020
Why?
Vaccination
1
2022
1449
0.020
Why?
Research Personnel
1
2015
190
0.020
Why?
Intestinal Absorption
1
1994
103
0.020
Why?
Pandemics
1
2021
1707
0.020
Why?
Triage
1
2015
243
0.020
Why?
Food
1
1994
149
0.020
Why?
Tomography, Emission-Computed
1
2012
71
0.020
Why?
Alcohol Drinking
1
2020
850
0.020
Why?
Equipment Failure
1
2013
112
0.020
Why?
Infusions, Intravenous
1
2013
432
0.020
Why?
Nuclear Proteins
1
2017
740
0.020
Why?
Oxygen Consumption
1
2015
721
0.020
Why?
Patient Protection and Affordable Care Act
1
2013
105
0.020
Why?
Medical Audit
1
2012
78
0.020
Why?
Hemodynamics
1
1997
1114
0.020
Why?
Electrodes, Implanted
1
2013
114
0.020
Why?
Blood Cell Count
1
2012
56
0.020
Why?
Urinary Bladder Neoplasms
1
1995
259
0.020
Why?
Occupational Exposure
1
2015
356
0.020
Why?
Foundations
1
2011
27
0.020
Why?
Dementia
1
2015
324
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2017
992
0.020
Why?
Self Report
1
2015
870
0.020
Why?
Environmental Exposure
1
2015
578
0.020
Why?
Ankle Brachial Index
1
2010
41
0.020
Why?
Lung Diseases
1
2017
787
0.020
Why?
Computer Simulation
1
2014
1014
0.020
Why?
Health Planning Guidelines
1
2010
23
0.020
Why?
Patients
1
2011
183
0.020
Why?
Organizational Objectives
1
2010
67
0.020
Why?
Withholding Treatment
1
2010
77
0.020
Why?
Smoking
1
2016
1486
0.020
Why?
Sensitivity and Specificity
2
2008
1998
0.020
Why?
Aortic Diseases
1
2010
125
0.020
Why?
Life Tables
1
2009
21
0.020
Why?
Iatrogenic Disease
1
2009
74
0.020
Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2008
103
0.020
Why?
Leadership
1
2013
414
0.020
Why?
Regional Health Planning
1
2008
8
0.020
Why?
Intestinal Mucosa
1
1994
666
0.020
Why?
Prostatic Neoplasms
1
1995
972
0.020
Why?
Public Health
1
2013
574
0.020
Why?
Drug Labeling
1
2007
37
0.020
Why?
Time and Motion Studies
1
2007
29
0.020
Why?
Vitamin E
1
1988
123
0.020
Why?
Melanoma, Experimental
1
1988
106
0.020
Why?
Prospective Payment System
1
2007
15
0.020
Why?
Electronic Health Records
1
2015
1210
0.020
Why?
Intensive Care Units
1
2013
925
0.020
Why?
Fees, Medical
1
2006
9
0.020
Why?
Blood Pressure Determination
1
2008
143
0.020
Why?
Phenotype
1
2015
3206
0.020
Why?
Diagnostic Tests, Routine
1
2008
109
0.020
Why?
Disclosure
1
2007
91
0.020
Why?
North Carolina
1
2006
127
0.020
Why?
Europe
1
2007
421
0.020
Why?
Syndrome
1
2007
380
0.020
Why?
Cyclooxygenase Inhibitors
1
2006
82
0.010
Why?
Lovastatin
1
2006
37
0.010
Why?
Protein Kinases
1
1988
311
0.010
Why?
Information Dissemination
1
2008
226
0.010
Why?
Pravastatin
1
2006
45
0.010
Why?
Fatty Acids, Monounsaturated
1
2006
55
0.010
Why?
Heptanoic Acids
1
2006
67
0.010
Why?
Demography
1
2006
274
0.010
Why?
Exercise Therapy
1
2010
488
0.010
Why?
Hematocrit
1
2005
108
0.010
Why?
Midwestern United States
1
2004
45
0.010
Why?
Northwestern United States
1
2004
56
0.010
Why?
Pyrroles
1
2006
222
0.010
Why?
Disease-Free Survival
1
2006
778
0.010
Why?
Diabetic Nephropathies
1
2007
320
0.010
Why?
Diastole
1
2004
147
0.010
Why?
Veterans
1
2015
1650
0.010
Why?
Social Support
1
2007
646
0.010
Why?
Drug Interactions
1
2003
405
0.010
Why?
Bayes Theorem
1
2004
426
0.010
Why?
Indoles
1
2006
511
0.010
Why?
Child
2
2013
22693
0.010
Why?
Pyridines
1
2006
610
0.010
Why?
Counseling
1
2004
406
0.010
Why?
Neoplasms
1
2015
2954
0.010
Why?
Quality-Adjusted Life Years
1
1999
122
0.010
Why?
Endocarditis, Bacterial
1
1999
46
0.010
Why?
Echocardiography, Transesophageal
1
1999
132
0.010
Why?
Patient Care Team
1
2004
701
0.010
Why?
Alcoholism
1
2004
830
0.010
Why?
Child, Preschool
1
2013
11913
0.010
Why?
Diagnosis, Differential
1
1999
1503
0.010
Why?
Gadolinium DTPA
1
1995
70
0.010
Why?
Cystectomy
1
1995
46
0.010
Why?
Prostatectomy
1
1995
93
0.010
Why?
Jejunostomy
1
1994
13
0.010
Why?
Image Enhancement
1
1995
198
0.010
Why?
Intestinal Fistula
1
1994
17
0.010
Why?
Bupivacaine
1
1994
43
0.010
Why?
Enteric Nervous System
1
1994
26
0.010
Why?
Neoplasm Invasiveness
1
1995
504
0.010
Why?
Nerve Block
1
1994
114
0.010
Why?
Dogs
1
1994
517
0.010
Why?
Synaptic Transmission
1
1994
294
0.010
Why?
Prostaglandins A
1
1988
9
0.000
Why?
Tocopherols
1
1988
32
0.000
Why?
Cyclic AMP
1
1988
208
0.000
Why?
Tumor Cells, Cultured
1
1988
882
0.000
Why?
Cell Survival
1
1988
1105
0.000
Why?
Animals
2
1994
38107
0.000
Why?
Mice
1
1988
18297
0.000
Why?
Masoudi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)